Allos Therapeutics, Inc. to Present at the Eighth Annual JMP Securities Research Conference

WESTMINSTER, Colo.--(BUSINESS WIRE)--Allos Therapeutics, Inc. (NASDAQ:ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company’s senior management will present on Tuesday, May 19, at 12:00 p.m. Pacific Time at the Eighth Annual JMP Securities Research Conference taking place at the Ritz-Carlton in San Francisco.

Back to news